SEC Form 4 · accession 0001274644-16-000136
Ocera Therapeutics, Inc. · OCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stan Bukofzer
Officer — Chief Medical Officer
Period of report
Oct 13, 2016
Accepted (ET)
Oct 17, 2016 · 8:28 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001274644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 13, 2016 | P | 2,500 | $2.639 | A | 2,500 | D |
Table II — derivative securities
No Table II lines on this filing.